BizSugar.com › Raising Capital › Exposing The Myths Surrounding Biotech Venture Capital- Ventury Capital

There are a lot of myths about biotech venture capital. Most of these myths concern returns, what works, what doesn’t work, and the state of the industry. Since they are talked about so often, most people believe these myths to be true, even practitioners, limited partners and pundits. There are a lot of studies and data that address these myths; here we will discuss the six top misconceptions about biotech venture capital.